@article{lin7644,
    title   = {Characterization of a clinical Clostridioides difficile isolate with markedly reduced fidaxomicin susceptibility and a V1143D mutation in rpoB.},    
    author  = {Schwanbeck J, Riedel T, Laukien F, Schober I, Oehmig I, Zimmermann O, Overmann J, Gross U, Zautner AE, Bohne W},    
    journal = {J Antimicrob Chemother},    
    year    = {2019},    
    doi     = {10.1093/jac/dky375},    
    pmid    = {30247587}        
    }
    @article{lin322002,
    title   = {Myxopyronin B inhibits growth of a Fidaxomicin-resistant Clostridioides difficile isolate and interferes with toxin synthesis.},    
    author  = {Brauer M, Herrmann J, Zuhlke D, Muller R, Riedel K, Sievers S.},    
    journal = {Gut Pathog},    
    year    = {2022},    
    doi     = {10.1186/s13099-021-00475-9},    
    pmid    = {34991700}        
    }
    @article{lin322001,
    title   = {Detection and Genomic Characterisation of <i>Clostridioides difficile</i> from Spinach Fields.},    
    author  = {Marcos P, Whyte P, Burgess C, Ekhlas D, Bolton D.},    
    journal = {Pathogens},    
    year    = {2022},    
    doi     = {10.3390/pathogens11111310},    
    pmid    = {36365061}        
    }